Gastrointestinal stromal tumors (GISTs) represent the most common mesenchymal neoplasms of the GI tract. The optimal management of GISTs has been evolving rapidly over the past 5 years and depends on proper histopathologic and radiologic diagnosis as well as appropriate multidisciplinary medical and surgical treatments. Complete surgical resection of primary localized GIST with negative margins remains the best therapeutic option today. In the setting of locally advanced or metastatic disease, imatinib mesylate has emerged as the initial treatment of choice, administered either as cytoreductive or as definitive treatment. Surgery or ablative modalities in this setting are becoming increasingly employed, particularly when all disease becomes amenable to gross resection or destruction, or to manage complications arising from the disease following imatinib failure.We report on the surgical management of an unusual and clinically significant complication following progression of disease secondary to imatinib resistance. The role of surgical therapy in the management of GIST complications following resistance to imatinib and the integration of surgical and molecular therapy of locally advanced or metastatic GISTs are discussed. The Oncologist 2007;12:438 -442 Disclosure of potential conflicts of interest is found at the end of this article. CASE PRESENTATIONA 49-year-old female patient presented with a severalmonth history of progressive fatigue, upper abdominal discomfort, and weight loss. On physical examination, she was noted to have a palpable mass in the epigastric area. She underwent evaluation with a computed tomography (CT) scan of the abdomen and pelvis which revealed a large solid mass occupying most of the upper abdomen and the lesser sac, most likely of gastric origin, though the exact source could not be well defined. There were no separation planes seen on the CT scan between the mass and the pancreatic tissue in the body and tail area. In addition, multiple hypodense lesions were noted in segments II, IV, V, and VII of the liver (Fig. 1A, 1B).Upper endoscopy revealed a raised 5-cm ϫ 6-cm hard, submucosal mass extending from the cardia/fundus into the lesser curve. Endoscopic ultrasonography (EUS) was performed, revealing that the hypoechoic mass was arising from the fourth layer of the gastric wall (corresponding to the muscularis propria), highly suggestive of gastrointestinal stromal tumor (GIST). Deep well endoscopic biopsies were obtained and showed a stromal cell tumor with high
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.